ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Cancer Research

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12374672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

  2001cited by this paper
• Molecular genetic alterations on chromosomes 11 and 22 in ependymomas

  2001cited by this paper
• Neuregulin and ErbB receptor signaling pathways in the nervous system.

  2001cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• Erbb transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system

  2001cited by this paper
• Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.

  2001cited by this paper
• Clinical and molecular stratification of disease risk in medulloblastoma

  2001cited by this paper
• Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Akt-Mediated Survival of Oligodendrocytes Induced by Neuregulins

  2000cited by this paper
• A Natural ErbB4 Isoform That Does Not Activate Phosphoinositide 3-Kinase Mediates Proliferation but Not Survival or Chemotaxis*

  2000cited by this paper
• The ErbB signaling network: receptor heterodimerization in development and cancer

  2000cited by this paper
• Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.

  1999cited by this paper
• A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors.

  1999cited by this paper
• Karyotype studies in 18 ependymomas with literature review of 107 cases.

  1999cited by this paper
• Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase

  1999cited by this paper
• Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.

  1999cited by this paper
• Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.

  1998cited by this paper
• Ependymomas: MIB-1 proliferation index and survival

  1998cited by this paper
• Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation.

  1998cited by this paper
• ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network

  1998cited by this paper
• Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.

  1998cited by this paper
• Prognosis of ependymoma

  1998cited by this paper
• Two erbB-4 transcripts are expressed in normal breast and in most breast cancers

  1998cited by this paper
• Ki‐67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas

  1998cited by this paper
• A new view of early cortical development.

  1998cited by this paper
• Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood

  1997cited by this paper
• Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis.

  1997cited by this paper
• Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.

  1997influential reference
• Mitotic percentage index: a new prognostic factor for childhood medulloblastoma.

  1997cited by this paper
• A Novel Juxtamembrane Domain Isoform of HER4/ErbB4

  1997cited by this paper
• Transformation of NIH 3T3 Cells by HER3 or HER4 Receptors Requires the Presence of HER1 or HER2 (*)

  1996cited by this paper
• Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas

  1996cited by this paper
• Molecular analysis of genetic changes in ependymomas

  1995cited by this paper

• Identification of Hub Genes in Ependymoma Through Weighted Gene Co-Expression Network Analysis

  2025cites this paper
• A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function

  2025cites this paper
• Pharmacological Phase I Clinical Trials in Pediatric Brain Tumors (1990–2024): A Historical Perspective

  2025cites this paper
• Gastrin-Releasing Peptide Receptors Stimulate MAPK-Mediated Growth of Lung Cancer Cells by Transactivating HER4 in a Neuregulin-1, MAP Kinase-Dependent Manner Requiring Activation of the ROS-System

  2025cites this paper
• Intracranial ependymomas in pediatric patients: patterns of care, disparities, and survival outcomes from the National Cancer Database.

  2024cites this paper
• Direct Administration of Chemotherapy and Other Agents into the Fourth Ventricle to Treat Recurrent Malignant Brain Tumors in Children.

  2024cites this paper
• Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial.

  2023cites this paper
• Latest classification of ependymoma in the molecular era and advances in its treatment: a review.

  2023cites this paper
• Diffuse Intrinsic Pontine Gliomas: Will there Ever be a Light at the End of the Dark Tunnel?

  2023cites this paper
• Human Patient-Derived Brain Tumor Models to Recapitulate Ependymoma Tumor Vasculature

  2023cites this paper
• ErbB4 in the brain: Focus on high grade glioma

  2022influential citation
• Advances on Epigenetic Drugs for Pediatric Brain Tumors

  2022cites this paper
• The biology of ependymomas and emerging novel therapies

  2022cites this paper
• The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein

  2022cites this paper
• Diffuse intrinsic pontine glioma: current insights and future directions

  2021cites this paper
• Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma

  2021cites this paper
• Targeted Therapy with Sirolimus and Nivolumab in a Child with Refractory Multifocal Anaplastic Ependymoma

  2021cites this paper
• Molecular subtyping of ependymoma and prognostic impact of Ki-67

  2021cites this paper
• Nimotuzumab therapy in the treatment of pediatric central nervous system tumors: single-center experience

  2021cites this paper
• Tumor Spheroids of an Aggressive Form of Central Neurocytoma Have Transit-Amplifying Progenitor Characteristics with Enhanced EGFR and Tumor Stem Cell Signaling

  2021cites this paper
• Receptor Tyrosine Kinases: Principles and Functions in Glioma Invasion.

  2020cites this paper
• Intracranial ependymomas: molecular insights and translation to treatment

  2020cites this paper
• Cancer of the Central Nervous System

  2020cites this paper
• A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma.

  2020cites this paper
• HER family in cancer progression: From discovery to 2020 and beyond.

  2020cites this paper
• CAR T-Cell Therapy for CNS Malignancies

  2020cites this paper
• Molecular Characteristics of Pediatric Ependymomas: A Systematic Review

  2019cites this paper
• The Role of Histone Modifying Enzyme SUV 420 H 2 in Pediatric Ependymoma

  2019cites this paper
• Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas

  2019cites this paper
• 3 Important Pathways in Glioma Biology 3 . 1 RTK / RAS / PI ( 3 K ) , P 53 , Rb

  2019cites this paper
• Global Reduction of H 3 K 4 me 3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas 1

  2019cites this paper
• Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response

  2018cites this paper
• Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models

  2018cites this paper
• Case-based review: ependymomas in adults.

  2018cites this paper
• Precision Medicine in Pediatric Neurooncology: A Review

  2017cites this paper
• Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival

  2017cites this paper
• Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma

  2017cites this paper
• Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies

  2017cites this paper
• 6 Malignant Brain Tumors in Childhood

  2017cites this paper
• Recent perspectives of ependymomas (childhood brain tumors).

  2017cites this paper
• Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities

  2016cites this paper
• The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective

  2016cites this paper
• Pediatric Ependymoma

  2016cites this paper
• Spinal cord ependymoma: a review of the literature and case series of ten patients

  2016cites this paper
• ERBB4 gene polymorphisms and the risk of prostate cancer in a sample of Iranian Population.

  2016cites this paper
• Biology and management of ependymomas.

  2016cites this paper
• [Pediatric ependymomas: Current diagnosis and therapy].

  2016cites this paper
• The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors

  2016cites this paper
• Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches

  2016cites this paper
• Investigating therapies in ependymoma

  2016cites this paper
• Expression of glial acidic fibrillary protein delta and E-cadherin in ependymomas; clinic-pathological and immunohistochemistry correlation

  2015influential citation
• Anatomical, molecular and pathological consideration of the circumventricular organs.

  2015cites this paper
• Growth-Factor-Driven Rescue to Receptor Tyrosine Kinase (RTK) Inhibitors through Akt and Erk Phosphorylation in Pediatric Low Grade Astrocytoma and Ependymoma

  2015cites this paper
• Advances in Management of Pediatric Ependymomas

  2015cites this paper
• Molecular Biology of Pediatric Brain Tumors and Impact on Novel Therapies

  2015cites this paper
• The EGFR/ERBB Receptor Family

  2015cites this paper
• Identification of glioma-associated antigens for brain tumor immunotherapy

  2015cites this paper
• An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)

  2015cites this paper
• Targeted Therapies in Paediatric Brain Tumours

  2015cites this paper
• The Role of Histone Modifying Enzyme SUV420H2 in Pediatric Ependymoma.

  2015cites this paper
• Glioma biology and molecular markers.

  2015cites this paper
• Clinicopathological features of myxopapillary ependymoma.

  2014cites this paper
• Genetic variation of ErbB4 confers risk of colorectal cancer in a Chinese Han population

  2014cites this paper
• Nf 2 / Merlin Controls Spinal Cord Neural Progenitor Function in a Rac 1 / ErbB 2-Dependent Manner

  2014cites this paper
• miR-193a-3p Functions as a Tumor Suppressor in Lung Cancer by Down-regulating ERBB4*

  2014cites this paper
• The Genetic and Epigenetic Basis of Posterior Fossa Ependymoma

  2014cites this paper
• Timing of adjuvant radiotherapy and treatment outcome in childhood ependymoma

  2014cites this paper
• Nf2/Merlin Controls Spinal Cord Neural Progenitor Function in a Rac1/ErbB2-Dependent Manner

  2014cites this paper
• Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells

  2014cites this paper
• Using genomics for drug discovery in medulloblastoma

  2014cites this paper
• Expression of the EGF Family in Gastric Cancer: Downregulation of HER4 and Its Activating Ligand NRG4

  2014cites this paper
• Telomerase as a Prognostic Marker and Therapeutic Target in Paediatric Ependymoma

  2013cites this paper
• Current and evolving knowledge of prognostic factors for pediatric ependymomas.

  2013cites this paper
• Receptor tyrosine kinases: principles and functions in glioma invasion.

  2013cites this paper
• Molecular characterization of circumventricular organs and third ventricle ependyma in the rat: potential markers for periventricular tumors

  2013cites this paper
• Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.

  2013cites this paper
• Ependymoma in children: molecular considerations and therapeutic insights

  2013influential citation
• PI3K Pathway Activation Provides a Novel Therapeutic Target for Pediatric Ependymoma and Is an Independent Marker of Progression-Free Survival

  2013cites this paper
• C-erbB2/HER2 in Human Gliomas, Medulloblastomas, and Meningiomas

  2013cites this paper
• A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study

  2013cites this paper
• Novel Functions of ErbB 4 and NRG-1 in Development and Cancer by Ilkka Paatero

  2013cites this paper
• Current Treatment Options for Pediatric and Adult Patients With Ependymoma

  2012cites this paper
• Khalida WaniTerri S. ArmstrongElizabeth Vera-BolanosAditya RaghunathanDavid Ellison • Richard GilbertsonBrian VaillantStewart GoldmanRoger J. PackerMaryam FouladiIan Pollack • Tom MikkelsenMichael PradosAntonio OmuroRiccardo SoffiettiAlicia LedouxCharmaine Wilson • Lihong LongMark R. GilbertKen Alda

  2012cites this paper
• Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models

  2012cites this paper
• A prognostic gene expression signature in infratentorial ependymoma

  2012cites this paper
• Intracranial Ependymoma: Role for Chemotherapy

  2012cites this paper
• 9 – Histopathology of brain tumors

  2012cites this paper
• EGFR as a predictor of relapse in myxopapillary ependymoma

  2012cites this paper
• Pediatric neuro‐oncology: Current status and future directions

  2012cites this paper
• Biologically targeted therapeutics in pediatric brain tumors.

  2012cites this paper
• Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis.

  2012cites this paper
• Anaplastic Glioma

  2012cites this paper
• A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation

  2012cites this paper
• Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy.

  2011cites this paper
• Posterior fossa ependymomas: a tale of two subtypes.

  2011cites this paper
• Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors.

  2011cites this paper
• Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

  2011cites this paper
• Molecular genetics of ependymoma

  2011cites this paper
• Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.

  2011cites this paper
• Childhood Brain Tumors

  2011cites this paper